BOCA RATON, Fla.-- (BUSINESS WIRE)--March 19, 2026-- ...

The global industry was valued at US$ 38.9 Bn in 2022 and is expected to register a CAGR of 7.1% from 2023 to 2031. Demand for biologics, biosimilars, and other biopharmaceuticals is growing at a ...

Report outlines how measuring supply chain fragility can guide policy, investment and procurement reformST. LOUIS, March 10, 2026 (GLOBE NEWSWIRE) -- The API Innovation Center (APIIC), a nonprofit ...

EAST RUTHERFORD, N.J., Sept. 26, 2017 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), ...

BEIJING--(BUSINESS WIRE)--Pharmaron Beijing Co., Limited (Stock Code: 300759.SZ/3759.HK) (“Pharmaron”) announced today that it has entered into a definitive Asset Purchase Agreement to acquire the ...

EAST RUTHERFORD, N.J., Oct. 22, 2025 /PRNewswire/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO), today announced a $120 million investment to expand its U.S.

U.S. Active Pharmaceutical Ingredients (APIs) Market · GlobeNewswire Inc. Dublin, Dec. 03, 2025 (GLOBE NEWSWIRE) -- The "United States Active Pharmaceutical Ingredients (APIs) Market - Growth, Trends ...

Pakistan's pharmaceutical industry, valued at Rs. 748 billion, faces challenges with API imports. Localizing API production could enhance economic stability and healthcare affordability.

HAMBURG, GERMANY / ACCESSWIRE / November 5, 2024 / Evotec SE (Frankfurt Stock Exchange:EVT)(MDAX/TecDAX, ISIN: DE0005664809)(NASDAQ:EVO) has announced the sale of its chemical API manufacturing site, ...

DUBLIN, July 10, 2020 /PRNewswire/ -- The "Peptide Therapeutics: Contract API Manufacturing Market, 2020-2030" report has been added to ResearchAndMarkets.com's offering. This report features an ...